Entrada Therapeutics

TRDA

5.8304.11% ( -0.250 )

Closed: Jul 28, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Entrada Therapeutics(TRDA) predict that the Revenue is 875 K (-95.74%), Miss estimate;the EBIT is -42.3 M (-94.14%), Beat estimate;the EPS is -0.95 (-126.2%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B95.74%

0.00B85.80%

-0.00B9.94%

EBITExceed expectations

-0.04B94.14%

-0.04B94.90%

+0.00B0.76%

EPSExceed expectations

-0.95126.19%

-1.0886159.18%

+0.138632.99%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD